We identified that CYP19A1, the rate-limiting enzyme in estrogen biosynthesis, is the direct target gene of miR-1270, and the expression of CYP19A1 was significantly higher in GCs from patients with PCOS. This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.